X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Prophylactic HIV Drugs Companies

This report lists the top Prophylactic HIV Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Prophylactic HIV Drugs industry.

Prophylactic HIV Drugs Top Companies

  1. Merck & Co., Inc.

  2. Cipla Inc

  3. Bristol-Myers Squibb Company

  4. Viatris Inc. (Mylan)

  5. Johnson & Johnson

*Disclaimer: Top companies sorted in no particular order

 Prophylactic HIV Drugs Market Major Players

Prophylactic HIV Drugs Market Concentration

Prophylactic HIV Drugs Market Concentration

Prophylactic HIV Drugs Company List

                            • AbbVie

                            • SK Capital (APOTEX INC.)

                            • Boehringer Ingelheim International GmbH

                            • Bristol-Myers Squibb Company

                            • Cipla Inc.

                            • GalaxoSmithKline PLC

                            • F. Hoffmann-La Roche AG (Genentech Inc.)

                            • Gilead Sciences Inc.

                            • Johnson & Johnson

                            • Merck & Co. Inc.

                            • Viatris Inc. (Mylan)

                            • Pfizer Inc.

                            • Teva Pharmaceutical Industries Ltd

                            • GlaxoSmithKline plc (ViiV Healthcare Group of Companies)


                        Specific to Prophylactic HIV Drugs Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Prophylactic HIV Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)